Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00549991 · ClinicalTrials.gov registry record
Analyzing Genes That May Increase the Risk of Developing High Blood Pressure
A clinical trial, sponsored by Case Western Reserve University.
- Completed
- Registry status
- 8,687
- Enrollment target
NCT00549991 is a clinical trial that has completed, run by Case Western Reserve University. The registered enrollment target is 8,687 participants.
The verdict
NCT00549991 has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- 8,687 participants
- Enrollment target
Study Summary
High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,687 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00549991
The ClinicalTrials.gov registry entry for NCT00549991 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8,687 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00549991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00549991 about?
NCT00549991 is a clinical study titled "Analyzing Genes That May Increase the Risk of Developing High Blood Pressure". High blood pressure is one of the most common health problems in the United States. Genetic variations may cause some people to be more susceptible to developing high blood pressure. This study will identify variations in genes known to play a part in the development of high blood pressure.
What is the current status of trial NCT00549991?
This trial is currently completed. The enrollment target is 8,687 participants. The study started on 2007-08. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00549991?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.